Second-leading cancer killer on the rise in young adults
March 20th, 2019
Dr. John Marshall talks with 7 On Your Side WJLA-TV, about Colon Cancer on the rise in young adults.
New Colon Cancer Concerns
Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients
The 2018 Ruesch Center Annual Report
Highlights of the Ruesch Center from the past year include our latest in research and clinical trials, partnerships regionally and internationally, and our education, advocacy and outreach efforts.
Patient & Families
Relentlessly fighting a smarter war against GI cancer by partnering with patients based on their unique needs, the Ruesch Center is committed to providing you with the highest standard of care and individualized cures.
Current Clinical Trials
Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
When you have stage 4 cancer, the shutdown is about more than a missed paycheck
January 25th, 2019
A federal employee with colon cancer grapples with complicated insurance problems as a result of the partial government shutdown.
Genomic and Transcriptomic Profiling Finds Potential Predictors and Therapeutic Targets in Pancreatic Cancer
January 25th, 2019
Dr. Michael Pishvaian’s talk on the prognostic value of HR-DDR mutations in Pancreatic Cancer from ASCO GI is highlighted in ASCO Daily News.
Immunotherapy Could Have Role in Frontline HCC
January 23rd, 2019
In the search to establish new therapeutic options for patients with advanced hepatocellular carcinoma (HCC), immunotherapy has become a frontrunner in many clinical trials in the first-line setting, according to Michael J. Pishvaian, MD, PhD.
Looking for Zebras in Metastatic Colorectal Cancer
January 7th, 2019
Although colorectal cancer is one of the most commonly diagnosed cancers in the United States,1 and researchers’ understanding of the biology and pathophysiology of CRC has grown, its many variations require that each case be diagnosed with care.
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.